^
    Back
    Association details:
    Biomarker:MSI-L/dMMR + KRAS G12V
    Cancer:Colorectal Cancer
    Regimen:FOLFIRI (irinotecan + leucovorin calcium + 5-fluorouracil)
    Direction:Resistant
    Evidence:
    Evidence Level:
    Resistant: C4 – Case Studies
    New
    Source:
    SAGE Open Med Case Rep
    Title:

    Effective management of advanced colon cancer genotyping microsatellite stable/microsatellite instable-low with Kirsten rat sarcoma viral oncogene mutation using nivolumab plus ipilimumab combined with regorafenib and irinotecan: A case report

    Published date:
    06/07/2021
    Excerpt:
    Here, we report a case of a 37-year-old man with advanced colorectal cancer genotyping microsatellite stable/microsatellite instable-low with a Kirsten rat sarcoma viral oncogene (G12V) mutation. the patient did not response to the common recommended chemotherapy FOLFIRI regimen...
    DOI:
    10.1177/2050313X211027737